Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Maloney

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Gene|February 8, 2012
Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's diseaseBryan Maloney, Debomoy K Lahiri
Epigenomics|December 19, 2012
Gene × environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS)Debomoy K Lahiri, Bryan Maloney
Experimental Gerontology|January 13, 2010
The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial stepsDebomoy K Lahiri, Bryan Maloney
Gene|June 25, 2011
The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motifBryan Maloney, Debomoy K Lahiri
Experimental Neurology|May 11, 2010
Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implicationsDebomoy K Lahiri, Bryan Maloney
The Lancet. Neurology|June 16, 2016
Epigenetics of dementia: understanding the disease as a transformation rather than a stateBryan Maloney, Debomoy K Lahiri
Journal of Alzheimer'S Disease : JAD|May 5, 2012
The "LEARn" (latent early-life associated regulation) model: an epigenetic pathway linking metabolic and cognitive disordersDebomoy K Lahiri, Bryan Maloney
The Journal of Biological Chemistry|June 16, 2019
APPealing for a role in cellular iron effluxDebomoy K Lahiri, Bryan Maloney, Ruizhi Wang
Gene|September 11, 2017
When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's authorDebomoy K Lahiri, Bryan Maloney, Kumar Sambamurti
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2005
Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's diseaseDebomoy K Lahiri, Yuan-Wen Ge, Bryan Maloney
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Gene|February 8, 2012
Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's diseaseBryan Maloney, Debomoy K Lahiri
Epigenomics|December 19, 2012
Gene × environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS)Debomoy K Lahiri, Bryan Maloney
Experimental Gerontology|January 13, 2010
The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial stepsDebomoy K Lahiri, Bryan Maloney
Gene|June 25, 2011
The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motifBryan Maloney, Debomoy K Lahiri
Experimental Neurology|May 11, 2010
Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implicationsDebomoy K Lahiri, Bryan Maloney
The Lancet. Neurology|June 16, 2016
Epigenetics of dementia: understanding the disease as a transformation rather than a stateBryan Maloney, Debomoy K Lahiri
Journal of Alzheimer'S Disease : JAD|May 5, 2012
The "LEARn" (latent early-life associated regulation) model: an epigenetic pathway linking metabolic and cognitive disordersDebomoy K Lahiri, Bryan Maloney
The Journal of Biological Chemistry|June 16, 2019
APPealing for a role in cellular iron effluxDebomoy K Lahiri, Bryan Maloney, Ruizhi Wang
Gene|September 11, 2017
When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's authorDebomoy K Lahiri, Bryan Maloney, Kumar Sambamurti
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2005
Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's diseaseDebomoy K Lahiri, Yuan-Wen Ge, Bryan Maloney
Pageof 8